Check Moderna, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.7B
EPS (TTM)
-9.7831
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.85%
PE Ratio (TTM)
-5.08
Industry PE ratio
16.65525641025641
P/B Ratio
0PEG Ratio
0EBITDA
-3.1B
Revenue (TTM)
3.1B
Profit Margin
-94.31%
Return On Equity TTM
456589700.00%
Track how Moderna, Inc. P/E has moved over time to understand its valuation trends.
Moderna, Inc. in the last 5 years
Lowest (4.36x)
June 30, 2022
Today (-5.08x)
September 18, 2025
Industry (16.66x)
September 18, 2025
Highest (115.93x)
March 31, 2021
Today’s Price to Earnings Ratio: -5.08x
Compare market cap, revenue, PE, and other key metrics of Moderna, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $9.7B | -64.22% | -5.08 | -94.31% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Moderna, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moderna, Inc. investment value today
Current value as on today
₹41,741
Returns
Returns from Moderna, Inc. Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 31 analysts
54.84%
Buy
35.48%
Hold
9.68%
Sell
Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna, Inc.. Average target price of $44.25
Get share price movements and forecasts by analysts on Moderna, Inc..
What analysts predicted
41.92%UPSIDE
Target Price
$44.25
Current Price
$25.7
Analyzed by
31 Analysts
Target
$44.25
Moderna, Inc. target price $44.25, a slight upside of 41.92% compared to current price of $25.7. According to 31 analysts rating.
Investment in Moderna, Inc. Shares on INDmoney has grown by 86.86% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:86.86% versus previous 30 day period
Search interest for Moderna, Inc. Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:53% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 September
Tue, 04:36 PM
-Increased scrutiny over vaccine safety impacts Moderna's investment narrative amid ongoing R&D momentum.
Tue, 08:19 PM
-Moderna announces positive preliminary data for its updated Spikevax COVID-19 vaccine targeting the LP.8.1 variant.
Tue, 09:10 PM
-Moderna shares rise 4% after positive vaccine data; UBS maintains Buy rating with a $70 price target.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 107.0M → 142.0M (in $), with an average increase of 24.7% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, -1.12B → -825.0M (in $), with an average increase of 16.5% per quarter
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 132.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 193.3%
Price Dip
In the last 1 month, MRNA stock has moved down by -11.0%
Organisation | Moderna, Inc. |
Headquarters | 325 Binney Street, Cambridge, MA, United States, 02142 |
Industry | Health Technology |
CEO | Mr. Stéphane Bancel |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Tracey Franklin | Chief People & Digital Technology Officer |
Mr. Dave Johnson | Chief Data & AI Officer |
Dr. Charbel Haber M.P.H., Ph.D. | Senior VP & Head of Global Regulatory Science |
Mr. Stéphane Bancel | CEO & Director |
Dr. Stephen Hoge M.D. | President |
Mr. James M. Mock | Chief Financial Officer |
Ms. Shannon Thyme Klinger J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer |
Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations |
Dr. Melanie Ivarsson M.B.A., O.B.E., Ph.D. | Chief Development Officer |
Moderna, Inc. share price today is $25.7 as on . Moderna, Inc. share today touched a day high of $25.92 and a low of $25.2.
Moderna, Inc. share touched a 52 week high of $73.35 on and a 52 week low of $23.15 on . Moderna, Inc. stock price today i.e. is trending at $25.7,which is 64.96% down from its 52 week high and 11.02% up from its 52 week low.
Moderna, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Moderna, Inc. (MRNA) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Moderna, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moderna, Inc. share’s latest price of $25.7 as on September 18, 2025 at 7:42 pm IST, you will get 0.3891 shares of Moderna, Inc.. Learn more about
fractional shares .
Moderna, Inc. stock has given -64.22% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?